Engaged in the R&D, production and sales of cardiovascular disease plant intervention diagnosis and treatment equipment and cardiovascular drugs.
Lepu Medical, founded in June, 1999 and headquartered in Beijing, is an enterprise engaged in the R&D, production and sales of cardiovascular drugs and cardiovascular disease plant interventional diagnosis and treatment equipment . The founder is Pu Zhongjie. Listed on the SZSE on October 30, 2009, the company's major shareholders are Luoyang Ship Material Research Institute, Pu Zhongjie and WP Medical Technologies, INC. Rivals that have direct and indirect competition with Lepu Medical include Peijia, Kintor, Aprea Therapeutics, Viela, etc.
ResearchConsumer Staples, Healthcare, Technology
WIA2020 | Rising Tech Stars 2020: Global & China's 100
Yunnan Baiyao's Revenue Rises 33%; Net Profit Falls 40% in 1Q 2021
On April 27, Yunnan Baiyao released a report for the first quarter of 2021 showing that the company's total operating revenue for the first quarter was 10.33 billion yuan, up 33.4% year-on-year; its operating profit was 880 million yuan, down 41.8% year-on-year; its net profit attributable to shareholders of the listed company was 760 million yuan.
Apr 30, 2021 02:07 AM
WIM2020: Insights on the Post-pandemic Outlook for the Healthcare Industry
The curtain came down on Dec 10 on the 'Healthtech Industry and COVID-19 Pandemic' Chapter at WIM 2020. Healthtech entrepreneurs and investors gathered to share insights on the outlook for the healthcare industry, covering topics like vaccination, AI healthcare, intelligent hardware, medical appliances and IVD.
Jan 07, 2021 02:10 PM